000 | 01934 a2200529 4500 | ||
---|---|---|---|
005 | 20250513123639.0 | ||
264 | 0 | _c19971002 | |
008 | 199710s 0 0 eng d | ||
022 | _a8756-0437 | ||
024 | 7 |
_a10.1002/(sici)1098-2388(199709/10)13:5<291::aid-ssu2>3.0.co;2-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohansson, S L | |
245 | 0 | 0 |
_aEpidemiology and etiology of bladder cancer. _h[electronic resource] |
260 |
_bSeminars in surgical oncology _c |
||
300 |
_a291-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAfrica _xepidemiology |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
650 | 0 | 4 |
_aArgentina _xepidemiology |
650 | 0 | 4 |
_aArsenic _xadverse effects |
650 | 0 | 4 |
_aBalkan Nephropathy _xcomplications |
650 | 0 | 4 |
_aCarcinogens _xadverse effects |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xepidemiology |
650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xepidemiology |
650 | 0 | 4 |
_aChile _xepidemiology |
650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
650 | 0 | 4 | _aDeveloped Countries |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMiddle East _xepidemiology |
650 | 0 | 4 |
_aNeoplasms, Radiation-Induced _xepidemiology |
650 | 0 | 4 | _aOccupational Exposure |
650 | 0 | 4 |
_aSchistosomiasis _xcomplications |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 |
_aSmoking _xadverse effects |
650 | 0 | 4 |
_aTaiwan _xepidemiology |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xepidemiology |
650 | 0 | 4 |
_aUterine Neoplasms _xradiotherapy |
700 | 1 | _aCohen, S M | |
773 | 0 |
_tSeminars in surgical oncology _gvol. 13 _gno. 5 _gp. 291-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1098-2388(199709/10)13:5<291::aid-ssu2>3.0.co;2-8 _zAvailable from publisher's website |
999 |
_c9238716 _d9238716 |